申请人:PROZYMEX AS
公开号:WO2012130299A1
公开(公告)日:2012-10-04
Novel compounds of the formula (I) wherein R1, R2, D, A, B and X have the meanings defined herein, pharmaceutical compositions comprising them as active ingredient, as well as their use in medicine, in particular as peptidase inhibitors, more specifically inhibitors of cysteine and/or serine peptidases useful in the treatment/prevention of inflammatory diseases.
公式(I)中的新化合物,其中R1、R2、D、A、B和X具有本文件中定义的含义,包含它们作为有效成分的药物组合物,以及它们在医学中的应用,特别是作为肽酶抑制剂,更具体地是用于治疗/预防炎症疾病的半胱氨酸和/或丝氨酸肽酶的抑制剂。